ARCHIVES

Congressional Committee, SEC Probe ImClone’s Statements To Shareholders.

This article is from The Cancer Letter archive.

Vol. 28 No. | March 8, 2002

Download PDF Visit The Full Archive

Related Articles

Ohio Center Helps Women Stop Smoking, Reduce Cervical Cancer Risk

October 29, 2004

Taxol Recommended For Second Line Therapy In Platinum-Resistant Metastatic Ovarian Cancer

November 20, 1992

Five NCAB members complete terms.

February 20, 2004

Arizona Cancer Center Seeks NCI Recognition As Comprehensive

May 29, 1987

Quality Oncology Wins Pilot Contract For Cancer Management In Fla.

July 27, 2001

Survivors Urge Congress To Include Oral Drug Coverage In Medicare Legislation

October 11, 2002